- Home
- KRO vs ATRC Comparison
KRO vs ATRC Comparison
Compare KRO & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRO
- ATRC
- Stock Information
- Founded
- KRO 1916
- ATRC 2000
- Country
- KRO United States
- ATRC United States
- Employees
- KRO N/A
- ATRC N/A
- Industry
- KRO Major Chemicals
- ATRC Medical/Dental Instruments
- Sector
- KRO Industrials
- ATRC Health Care
- Exchange
- KRO Nasdaq
- ATRC Nasdaq
- Market Cap
- KRO 803.0M
- ATRC 1.6B
- IPO Year
- KRO N/A
- ATRC 2005
- Fundamental
- Price
- KRO $6.48
- ATRC $30.72
- Analyst Decision
- KRO Strong Sell
- ATRC Strong Buy
- Analyst Count
- KRO 2
- ATRC 10
- Target Price
- KRO $7.75
- ATRC $49.50
- AVG Volume (30 Days)
- KRO 240.5K
- ATRC 404.1K
- Earning Date
- KRO 08-06-2025
- ATRC 07-29-2025
- Dividend Yield
- KRO 3.03%
- ATRC N/A
- EPS Growth
- KRO N/A
- ATRC N/A
- EPS
- KRO 0.84
- ATRC N/A
- Revenue
- KRO $1,898,100,000.00
- ATRC $480,076,000.00
- Revenue This Year
- KRO $8.42
- ATRC $14.63
- Revenue Next Year
- KRO $11.49
- ATRC $12.62
- P/E Ratio
- KRO $7.73
- ATRC N/A
- Revenue Growth
- KRO 10.42
- ATRC 15.79
- 52 Week Low
- KRO $5.86
- ATRC $20.20
- 52 Week High
- KRO $13.77
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- KRO 49.74
- ATRC 39.22
- Support Level
- KRO $6.32
- ATRC $31.00
- Resistance Level
- KRO $6.79
- ATRC $32.44
- Average True Range (ATR)
- KRO 0.23
- ATRC 1.03
- MACD
- KRO 0.06
- ATRC -0.09
- Stochastic Oscillator
- KRO 66.67
- ATRC 8.65
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.